REACH Compliance for Valve Seat Procurement

3. Where valve seat compliance actually fails: alloy, residue, and packaging

Valve seats are engineered for hot hardness, wear resistance, thermal conductivity, machinability, and fuel compatibility. Those performance needs drive complex metallurgy. Complexity is not a problem by itself; undocumented complexity is.

Review the risk in three layers.

1. Base material: the alloy may be acceptable, but it still has to be known

Sintered powder metal and alloy cast valve seats may contain chromium, molybdenum, nickel, cobalt, copper, tungsten, vanadium, manganese, and other elements. The presence of an element does not automatically mean a REACH failure. The relevant questions are: what is the chemical form, what is the concentration, is it intentionally added, is it restricted, and does the customer require reporting?

Compare the declared chemistry with the drawing, internal standard, or approved material specification. If the drawing sets hardness, density, or metallurgical requirements, compliance review should sit beside—not replace—PPAP/FAI and dimensional approval. The same part number, revision, and lot should connect the material certificate, hardness results, density record if sintered, and inspection data for outer diameter, inner diameter, height, concentricity, flatness, seat face angle, and surface roughness.

Ask extra questions when recycled feedstock, blended powder, or mixed melt sources are used. How are trace impurities controlled? How are batches segregated? What are the acceptance limits for lead, cadmium, mercury, and other residuals? If the customer says “not intentionally added,” define the expected evidence and the analytical detection limit separately.

Substances or groups that may need closer review, depending on form and use, include lead, cadmium, mercury, hexavalent chromium compounds, certain nickel or cobalt compounds, PAHs, phthalates in plastic packaging, and restricted flame retardants.

2. Process residue: the metal can pass while the finish creates the issue

A finished valve seat may leave the factory with machining-fluid residue, cleaning-agent traces, rust preventive oil, coating, phosphate treatment, or passivation chemistry. These materials are easy to miss because they are thin, invisible, or treated as “process aids.” They still belong in the compliance review if they remain on or contact the supplied article.

Request SDS documents, approved chemical lists, and declarations for post-machining and post-sintering materials. Ask practical questions:

• Is final cleaning aqueous, solvent-based, ultrasonic, or spray wash?
• Are parts fully dried before oiling?
• Is oil film controlled by weight, visual standard, corrosion test, or operator judgement?
• Are passivation or conversion coatings used?
• Are subcontracted coatings or treatments locked by supplier and revision?

Process chemicals should be controlled by trade name and revision. A change from one rust preventive, VCI paper, washer chemical, lubricant, or subcontracted coating to another should trigger compliance review before production release. If your customer prohibits hexavalent chromium, state that passivation or conversion coating chemistry must be Cr(VI)-free and supported by SDS and, where needed, test evidence.

3. Packaging contact: it can be inside the customer’s restricted substance scope

Valve seats may sit in VCI paper, plastic bags, cartons, or export packaging for weeks during sea freight and warehouse storage. Some customers include packaging in restricted substance reviews. Others require it only when packaging remains with the product through distribution. Either way, define the boundary.

Check VCI chemistry, plasticisers, printing inks, adhesives, desiccants, labels, and treated wood. For export shipments, confirm required pallet treatment markings where wood packaging is used. Packaging substitutions should be covered by supplier change control, especially when printed bags, VCI materials, or moisture inhibitors are customer-approved.

A focused verification list for reach compliance for valve seat sourcing should cover:

• SVHC screening against the latest ECHA Candidate List.
• Annex XVII restrictions relevant to supplied articles, surface treatments, oils, and packaging.
• No intentionally added lead, mercury, cadmium, or hexavalent chromium unless technically justified and legally permitted.
• Nickel, cobalt, or other reportable elements declared where customer disclosure rules require them.
• Rust preventive, washing agent, lubricant, and preservative residue controlled through an approved chemical list.
• Packaging compliance for inks, plasticisers, VCI materials, labels, desiccants, adhesives, and treated wood where applicable.
• Batch traceability linking certificate, inspection record, declaration, packaging lot if relevant, and shipment documents.

If a programme requires non-standard alloy content or a customer-controlled material, Driventus can support custom manufacturing with drawing-based metallurgy, process routing, and documented compliance review.

4. Approval workflow: the 12 gates before release

Do not wait until the shipment is packed to ask for REACH evidence. Build the checks into part approval. The same workflow works for new sourcing, dual sourcing, supplier transfer, material conversion, or a changed surface-treatment route.

Gate 1 — Market requirement. Record whether EU REACH, UK REACH, customer restricted substance lists, IMDS, SCIP support, or full material disclosure applies. Put the destination market on the RFQ and purchase order.

Gate 2 — Drawing revision. Lock the active drawing before reviewing declarations. Check material grade, hardness, dimensions, surface finish, heat treatment, sintering/casting route, coating, preservative, marking, and packaging.

Gate 3 — Acceptance numbers. List chemistry limits, hardness range, density if applicable, critical dimensions, surface roughness, prohibited substance thresholds, and any “not intentionally added” requirement.

Gate 4 — Controlled declarations. Require supplier name, valve seat part number, drawing revision, issue date, review basis, SVHC Candidate List review date, and authorised signature.

Gate 5 — Material evidence. Compare certificate values with drawing limits and known restricted or reportable substance concerns. Confirm that heat or batch numbers match samples or shipment lots.

Gate 6 — Post-processing chemicals. Review SDS files and approved chemical lists for washing agents, cutting fluids, rust preventives, coatings, passivation chemicals, VCI materials, and packaging contact materials.

Gate 7 — SVHC threshold assessment. If any Candidate List substance may exceed 0.1% w/w in the article as supplied, request concentration data, safe-use communication evidence, and SCIP support where required by the customer or importer.

Gate 8 — Test decision. Use XRF screening for metallic elements when it answers the question. Use targeted laboratory analysis when valence, compound form, organic substances, customer thresholds, or unclear documentation require it. Confirm detection limits before ordering.

Gate 9 — Change control. Require notification before changes to alloy, powder source, foundry route, heat treatment, coating, oil, washer chemistry, packaging, subcontractor, or production site. A 60- to 90-day notice period is practical for approved production parts unless an emergency deviation is agreed.

Gate 10 — Sample and document approval. Release mass production only after FAI/PPAP evidence, material certificate, REACH declaration, SDS review, test report if required, and packaging approval are linked to the same part revision.

Gate 11 — Record archive. Keep declarations, certificates, SDS files, test reports, purchase orders, inspection results, shipment traceability, and deviation approvals together for the retention period required by the customer or regulation.

Gate 12 — Periodic review. Refresh declarations when the SVHC Candidate List changes, when Annex XVII updates affect the product scope, when specification or process changes occur, or at least annually for active EU/UK programmes.

This workflow is not limited to valve seats. The same evidence logic can apply to pistons, valve guides, gaskets, water pumps, turbocharger components, and other engine parts. Buyers can review related categories under engine components.

For launch planning, separate the schedule into document review, sample production, laboratory testing, and commercial approval. Existing parts with current records may clear quickly. New alloys, new preservatives, new packaging systems, or new subcontracted treatments can add weeks because the supplier must validate the route, issue new certificates, obtain SDS confirmations, and sometimes wait for independent lab results. Put those gates into the programme timing plan before promising a customer launch date.

5. Testing is not a ritual: use it to answer a defined risk question

Testing every shipment of a stable valve seat is usually wasteful. Never testing a new or unclear supply chain is also risky. The useful middle ground is risk-based testing with a written question.

Examples of good test questions:

• Does the alloy composition match the certificate and drawing limits?
• Is a restricted substance present above the customer or regulatory threshold?
• Does the coating or passivation contain a prohibited substance form?
• Does the packaging material introduce phthalates, restricted flame retardants, or other controlled substances?
• Is the supplier’s declaration credible for this batch and surface condition?

Testing is most useful when one or more of these conditions apply:

• First article approval for a new valve seat supplier.
• Change in alloy source, powder supplier, foundry route, heat treatment, surface treatment, or subcontracted process.
• New coating, rust preventive, cleaning chemical, passivation process, VCI paper, plastic bag, or packaging system.
• Customer specification requires independent test evidence or an accredited laboratory report.
• Supplier declaration is incomplete, unsigned, generic, not part-specific, or older than the current SVHC review cycle.
• Material contains elements associated with restricted or reportable substances.
• Mixed recycled feedstock is used without strong traceability.
• Incoming inspection, audit findings, or field feedback suggests a material or process deviation.
• A buyer wants to validate a low-cost source before placing a larger blanket order.

Choose the method based on the question. XRF screening is fast and useful for metallic elements such as chromium, nickel, copper, molybdenum, cobalt, tungsten, and iron. It can compare alloy composition with the certificate. But XRF cannot always identify chemical valence or compound form. It may detect chromium, for example, but it cannot by itself distinguish chromium metal from hexavalent chromium compounds.

For hexavalent chromium, lead compounds, PAHs, phthalates, organotin compounds, flame retardants, or other substance forms, specify the analytical method and use an accredited laboratory where the customer or risk level requires it.

Set acceptance rules before samples are sent:

• Sample identity and valve seat part number.
• Drawing revision.
• Heat, batch, or lot number.
• Number of pieces tested.
• Surface condition: dry, oiled, coated, passivated, or as-packed.
• Whether packaging is included.
• Reporting units.
• Detection limits.
• Pass/fail thresholds.

If the requirement is below 0.1% w/w, confirm that the method reports comfortably below that level. If the customer demands a lower reporting threshold, state it in the lab purchase order. For metallic composition checks, compare results with drawing limits and certificate values while allowing for method uncertainty.

Testing frequency belongs in the control plan. A stable production valve seat may need approval testing, annual or periodic surveillance, and retesting after material, chemical, packaging, subcontractor, or site changes. New or higher-risk programmes may justify pilot-lot testing until process capability and document discipline are proven. Align this with the supplier’s IATF 16949:2016 change management and ISO 9001:2015 document control.

Cost and lead time should be visible. XRF is usually faster and less expensive than full wet chemistry or organic substance analysis. Targeted laboratory testing may add 10 to 20 working days; urgent service raises cost. Decide during RFQ whether testing is a one-time approval cost, a recurring surveillance charge, or amortised into unit price.

6. Commercial terms: make compliance enforceable before the first lot

REACH obligations should appear in the purchase agreement, supplier quality manual, technical specification, nomination letter, or purchase order terms. If they appear only after a problem, the buyer and supplier will argue about cost, timing, quarantine, retesting, and customer communication.

Useful clauses include:

• Supplier must comply with REACH (EC) No 1907/2006 for products supplied into the EU.
• Supplier must support UK REACH where the destination market includes Great Britain.
• Supplier must notify the buyer if any SVHC exceeds 0.1% w/w in the supplied article.
• Supplier must provide updated declarations after relevant SVHC Candidate List or regulatory updates, and at least annually for active programmes if requested.
• Supplier must notify the buyer before changes to material, powder source, foundry route, heat treatment, process chemicals, packaging, subcontractors, or manufacturing site.
• Supplier must provide supporting records within an agreed period, such as 5 to 10 working days for existing documents and an agreed laboratory lead time for new tests.
• Buyer may request third-party testing for reasonable compliance verification, with cost allocation defined for approval testing, surveillance, and failure investigation.
• Non-conforming or undocumented goods may be quarantined until acceptable evidence is supplied.
• Supplier must maintain lot traceability from raw material or powder batch through finished valve seat shipment.
• Supplier must flow down equivalent requirements to subcontractors for coating, heat treatment, cleaning, packaging, and external testing.

Then connect the clauses to price and MOQ. The lowest unit price usually comes from an existing approved alloy, standard tooling, normal anti-rust oil, standard VCI packaging, routine documentation, and consolidated production lots. Cost rises when the buyer asks for a custom alloy, low-volume dedicated melt or powder batch, special packaging, customer-specific IMDS/SCIP support, independent laboratory testing, or segregated production.

During RFQ comparison, separate these cost drivers:

• Tooling, die, fixture, or gauge cost for new dimensions.
• MOQ for raw material, powder blend, casting heat, sintering batch, or printed packaging.
• Unit price at sample, pilot, blanket-order, and mass-production volumes.
• Compliance documentation cost if not included in part price.
• Third-party testing and retesting cost.
• Lead time for samples, production, lab reports, sea freight, and safety stock build.

The aim is not paperwork for its own sake. The aim is a traceable evidence chain from drawing and material selection through production batch, shipment, and customer delivery. A concise compliance package reduces customs delays, supports distributor enquiries, and gives quality teams a clear basis for supplier audits.

Driventus supplies valve seats and related engine components to aftermarket distributors, wholesalers, OEM and Tier-1 programmes, and repair chain supply networks. For project review, share the drawing, annual volume, target market, required compliance format, target price level, requested MOQ, and launch date when you request a quote.